• Exagen will attend Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum in New York on Nov. 11, 2026.
• Management will participate in the “Innovative Diagnostics for Attractive Immunology Applications” panel at 10:30 a.m. ET.
• Executives will also meet investors at Craig-Hallum's Alpha Select Conference in New York on Nov. 17, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exagen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610290900PRIMZONEFULLFEED9855473) on October 29, 2026, and is solely responsible for the information contained therein.